Terms: = Liver cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Treatment
57 results:
1. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
[TBL] [Abstract] [Full Text] [Related]
2. The relationship between the use of nucleos(t)ide analogs and metabolic parameters in patients with chronic hepatitis B.
Yakut A; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9315-9323. PubMed ID: 37843345
[TBL] [Abstract] [Full Text] [Related]
3. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
4. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
5. Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand.
Dilokthornsakul P; Sawangjit R; Tangkijvanich P; Chayanupatkul M; Tanwandee T; Sukeepaisarnjaroen W; Sriuttha P; Permsuwan U
Appl Health Econ Health Policy; 2022 Jul; 20(4):587-596. PubMed ID: 35141850
[TBL] [Abstract] [Full Text] [Related]
6. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
Wang D; Eisen HJ
Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
[TBL] [Abstract] [Full Text] [Related]
7. Health benefits and phenolic compounds of Moringa oleifera leaves: A comprehensive review.
Hassan MA; Xu T; Tian Y; Zhong Y; Ali FAZ; Yang X; Lu B
Phytomedicine; 2021 Dec; 93():153771. PubMed ID: 34700271
[TBL] [Abstract] [Full Text] [Related]
8. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss.
Çetin M; Aydın AA; Karaman K
Cardiol Young; 2021 Aug; 31(8):1359-1362. PubMed ID: 33658088
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy.
Wu X; Zhou J; Sun Y; Ding H; Chen G; Xie W; Piao H; Xu X; Jiang W; Ma H; Ma A; Chen Y; Xu M; Cheng J; Xu Y; Meng T; Wang B; Chen S; Shi Y; Kong Y; Ou X; You H; Jia J
Hepatol Int; 2021 Feb; 15(1):82-92. PubMed ID: 33460002
[TBL] [Abstract] [Full Text] [Related]
10. Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
von Felden J; Craig AJ; Garcia-Lezana T; Labgaa I; Haber PK; D'Avola D; Asgharpour A; Dieterich D; Bonaccorso A; Torres-Martin M; Sia D; Sung MW; Tabrizian P; Schwartz M; Llovet JM; Villanueva A
Oncogene; 2021 Jan; 40(1):140-151. PubMed ID: 33097857
[TBL] [Abstract] [Full Text] [Related]
11. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/tsc2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract] [Full Text] [Related]
12. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
Wang X; Liu X; Dang Z; Yu L; Jiang Y; Wang X; Yan Z
Gut Liver; 2020 Mar; 14(2):232-247. PubMed ID: 31158948
[TBL] [Abstract] [Full Text] [Related]
13. Dissecting tsc2-mutated renal and hepatic angiomyolipomas in an individual with ARID1B-associated intellectual disability.
Popp B; Agaimy A; Kraus C; Knaup KX; Ekici AB; Uebe S; Reis A; Wiesener M; Zweier C
BMC Cancer; 2019 May; 19(1):435. PubMed ID: 31077186
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of liver cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
Caruso S; Calatayud AL; Pilet J; La Bella T; Rekik S; Imbeaud S; Letouzé E; Meunier L; Bayard Q; Rohr-Udilova N; Péneau C; Grasl-Kraupp B; de Koning L; Ouine B; Bioulac-Sage P; Couchy G; Calderaro J; Nault JC; Zucman-Rossi J; Rebouissou S
Gastroenterology; 2019 Sep; 157(3):760-776. PubMed ID: 31063779
[TBL] [Abstract] [Full Text] [Related]
15. High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Lin CC; Bair MJ; Liu CY; Lin ZY; Chen CJ; Chen MJ; Chu CH; Wang HY; Shih SC; Wang TE
Medicine (Baltimore); 2019 Jan; 98(1):e13818. PubMed ID: 30608393
[TBL] [Abstract] [Full Text] [Related]
16.
Kaur V; Kumar M; Kumar A; Kaur S
Drug Chem Toxicol; 2020 Jul; 43(4):398-408. PubMed ID: 30293450
[No Abstract] [Full Text] [Related]
17. Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study.
Kim HY; Yoo JJ; Oh S; Yu SJ; Kim YJ; Yoon JH; Kim W; Jung YJ; Kim BH; Kim CM; Park JW; Lee JH
J Med Virol; 2018 Oct; 90(10):1593-1603. PubMed ID: 29900560
[TBL] [Abstract] [Full Text] [Related]
18. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to tsc2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract] [Full Text] [Related]
19. Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).
Zhang Y; Jia QA; Kadel D; Zhang XF; Zhang QB
Med Sci Monit; 2018 May; 24():2735-2743. PubMed ID: 29720580
[TBL] [Abstract] [Full Text] [Related]
20. Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
Guo X; Wu J; Wei F; Ouyang Y; Li Q; Liu K; Wang Y; Zhang Y; Chen D
Int J Antimicrob Agents; 2018 Aug; 52(2):201-209. PubMed ID: 29654894
[TBL] [Abstract] [Full Text] [Related]
[Next]
